Skip to main content
  • Saved

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

Source : https://headachejournal.onlinelibrary.wiley.com/doi/full/10.1111/head.13642?af=R

Conflict of Interest: Richard B. Lipton, MD, serves on the editorial boards of Neurology and Cephalalgia and as senior advisor to Headache. He has received research support from the NIH. He also receives support from the Migraine Research Foundation and the National Headache Foundation. He has reviewed for the NIA and NINDS; he serves as consultant or advisory board member or has received honoraria from Alder, Allergan, Amgen, Autonomic Technologies, Avanir, Boston Scientific, Dr. Reddy's, ElectroCore, Eli Lilly, eNeura, GlaxoSmithKline, Merck, Novartis, Teva, and Vedanta.

Sign In or Register Today to Access This Content